THE ULTIMATE GUIDE TO TRASTUZUMAB BIOSIMILAR

In July 2024, the CHMP adopted a good feeling, recommending the granting of the advertising and marketing authorization with the medicinal product or service Tuznue, supposed for the treatment method of breast and gastric cancer.All drugs could cause side effects. However, Lots of people don't have any side effects or only have minimal side effects